These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Is mycophenolate mofetil an effective alternative in azathioprine-intolerant patients with chronic active Crohn's disease? Miehsler W; Reinisch W; Moser G; Gangl A; Vogelsang H Am J Gastroenterol; 2001 Mar; 96(3):782-7. PubMed ID: 11280551 [TBL] [Abstract][Full Text] [Related]
24. Effect and safety of mycophenolate mofetil in chronic pulmonary sarcoidosis: a retrospective study. Brill AK; Ott SR; Geiser T Respiration; 2013; 86(5):376-83. PubMed ID: 23295253 [TBL] [Abstract][Full Text] [Related]
25. Mycophenolate mofetil (CellCept): an alternative therapy for autoimmune inflammatory myopathy. Majithia V; Harisdangkul V Rheumatology (Oxford); 2005 Mar; 44(3):386-9. PubMed ID: 15572389 [TBL] [Abstract][Full Text] [Related]
26. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. The Mycophenolate Mofetil Renal Refractory Rejection Study Group. Transplantation; 1996 Mar; 61(5):722-9. PubMed ID: 8607174 [TBL] [Abstract][Full Text] [Related]
27. Candida Esophagitis Associated With Mycophenolate Mofetil Treatment of Atopic Dermatitis. Kurayev A; Gottlieb AB J Drugs Dermatol; 2016 Oct; 15(10):1267-1269. PubMed ID: 27741346 [TBL] [Abstract][Full Text] [Related]
34. Chronic actinic dermatitis treated with mycophenolate mofetil. Thomson MA; Stewart DG; Lewis HM Br J Dermatol; 2005 Apr; 152(4):784-6. PubMed ID: 15840115 [TBL] [Abstract][Full Text] [Related]
35. Prescribing practices for systemic agents in the treatment of severe pediatric atopic dermatitis in the US and Canada: The PeDRA TREAT survey. Totri CR; Eichenfield LF; Logan K; Proudfoot L; Schmitt J; Lara-Corrales I; Sugarman J; Tom W; Siegfried E; Cordoro K; Paller AS; Flohr C J Am Acad Dermatol; 2017 Feb; 76(2):281-285. PubMed ID: 27855965 [TBL] [Abstract][Full Text] [Related]
36. Treatment of chronic plaque-stage psoriasis and psoriatic arthritis with mycophenolate mofetil. Grundmann-Kollmann M; Mooser G; Schraeder P; Zollner T; Kaskel P; Ochsendorf F; Boehncke WH; Kerscher M; Kaufmann R; Peter RU J Am Acad Dermatol; 2000 May; 42(5 Pt 1):835-7. PubMed ID: 10775866 [TBL] [Abstract][Full Text] [Related]
38. Mycophenolate mofetil therapy for children with intractable nephrotic syndrome. Okada M; Sugimoto K; Yagi K; Yanagida H; Tabata N; Takemura T Pediatr Int; 2007 Dec; 49(6):933-7. PubMed ID: 18045300 [TBL] [Abstract][Full Text] [Related]
39. Mycophenolate mofetil may be effective in CNS sarcoidosis but not in sarcoid myopathy. Androdias G; Maillet D; Marignier R; Pinède L; Confavreux C; Broussolle C; Vukusic S; Sève P Neurology; 2011 Mar; 76(13):1168-72. PubMed ID: 21444902 [TBL] [Abstract][Full Text] [Related]
40. Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus. Chatur N; Ramji A; Bain VG; Ma MM; Marotta PJ; Ghent CN; Lilly LB; Heathcote EJ; Deschenes M; Lee SS; Steinbrecher UP; Yoshida EM Liver Int; 2005 Aug; 25(4):723-7. PubMed ID: 15998421 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]